Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · The Lancet · 1,124 citations
https://doi.org/10.1016/s0140-6736(20)31792-x
J
Jens Jakob Thune
Amager Hospital(DK)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
7.3K
Citations
38
h-index
65
i10-index
Jens Jakob Thune is an academic researcher from Amager Hospital. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Cardiac pacing and defibrillation studies & Cardiomyopathy and Myosin Studies. The author has an h-index of 38, co-authored 133 publications.
ORCID: 0000-0002-3621-3775Papers by this author
worksClinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
2020 · JACC Heart Failure · 141 citations
https://doi.org/10.1016/j.jchf.2020.11.003
2025 ESC Guidelines for the management of myocarditis and pericarditis
2025 · European Heart Journal · 139 citations
https://doi.org/10.1093/eurheartj/ehaf192
Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: A 9-year follow-up study
2014 · International Journal of Cardiology · 46 citations
https://doi.org/10.1016/j.ijcard.2014.12.090
Mechanisms and Predictors of Mitral Regurgitation after High-Risk Myocardial Infarction
2012 · Journal of the American Society of Echocardiography · 34 citations
https://doi.org/10.1016/j.echo.2012.01.006
Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis
2022 · European Journal of Preventive Cardiology · 30 citations
https://doi.org/10.1093/eurjpc/zwac219
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat